shed
tissu
distribut
quasispeci
composit
felin
coronavirus
studi
natur
experiment
infect
cat
infect
remain
subclin
major
anim
shed
viru
via
faec
throughout
experi
sequenc
correspond
viral
nucleocapsid
region
amplifi
reversetranscript
polymeras
chain
reaction
cortex
dura
mater
pancrea
lung
third
eyelid
heart
muscl
four
case
interestingli
viral
region
suppos
virul
factor
detect
fewer
organ
rais
possibl
region
affect
delet
viru
replic
vivo
demonstr
composit
viral
quasispeci
differ
organ
genom
region
differ
function
undergo
distinct
process
select
consid
evolut
felin
coronavirus
felin
coronavirus
fcov
member
famili
coronavirida
genom
consist
singlestrand
positivesens
rna
de
groot
et
al
luytj
regard
pathogen
fcov
compris
two
biotyp
felin
infecti
periton
fip
virus
fipv
felin
enter
coronavirus
fecv
pedersen
base
invitro
neutralis
use
monoclon
antibodi
exist
least
two
serotyp
fcov
type
ii
shown
serotyp
contain
virus
fipv
fecv
biotyp
hohdatsu
et
al
b
type
ii
virus
differ
vitro
growth
characterist
pedersen
importantli
composit
spike
protein
herrewegh
et
al
field
preval
fcov
type
seem
higher
sinc
per
cent
fip
case
due
infect
type
virus
hohdatsu
et
al
fip
highli
fatal
diseas
felida
foley
et
al
pathogenesi
diseas
still
fulli
understood
diagnosi
diseas
rather
complic
therefor
repres
one
major
pet
anim
health
problem
still
remain
solv
thu
serolog
data
alway
inform
olsen
diagnosi
vaccin
may
provid
protect
sinc
may
even
induc
acceler
pathogenesi
earli
death
associ
antibodydepend
enhanc
infect
vennema
et
al
harvey
et
al
nevertheless
commerci
avail
vaccin
shown
promis
result
fehr
et
al
fecv
consid
direct
caus
morbid
cat
may
produc
mild
enter
experiment
natur
infect
remain
subclin
howev
present
consider
health
risk
cat
reveal
parent
fipv
foley
et
al
vennema
et
al
recent
find
suggest
genet
chang
frequent
occur
felin
coronavirus
herrewegh
et
al
vennema
et
al
instanc
demonstr
type
ii
felin
coronavirus
arisen
rna
recombin
event
canin
coronaviru
type
felin
coronaviru
herrewegh
et
al
observ
indic
delet
differ
part
fecv
genom
may
respons
format
fip
virus
vennema
et
al
howev
mechan
event
total
understood
known
type
fecv
establish
persist
infect
cat
viru
replic
enterocyt
crypt
larg
intestin
viru
replic
specif
chang
viral
genom
may
lead
develop
highli
pathogen
fip
virus
consequ
manifest
diseas
possibl
malfunct
immun
system
contribut
process
poland
et
al
laboratori
diagnosi
control
fip
serious
hamper
failur
fcov
replic
cell
cultur
consid
fact
aim
studi
develop
appli
effici
approach
detect
differenti
fcov
subpopul
use
techniqu
investig
persist
distribut
quasispeci
composit
fcov
natur
experiment
infect
cat
order
mimic
natur
condit
randomli
select
mixedbre
domest
cat
gender
use
anim
origin
vendor
clinic
healthi
month
age
cat
immunis
vaccin
faec
cat
no
posit
fcov
use
reversetranscript
polymeras
chain
reaction
rtpcr
therefor
anim
regard
carrier
remain
eight
cat
repeatedli
neg
fcov
start
experi
six
fcov
free
anim
no
experiment
infect
fcov
two
cat
no
use
neg
control
anim
kept
room
separ
cage
physic
contact
fed
commerci
avail
cat
food
milk
fresh
water
faecal
sampl
collect
cat
no
begin
experi
fresh
sampl
pool
homogenis
pb
wv
centrifug
g
minut
supernat
fluid
given
oral
six
fcov
free
cat
no
dose
ml
cat
neg
control
fcov
carrier
mockinfect
pb
cat
monitor
daili
clinic
sign
rectal
swab
sampl
collect
day
start
experi
day
experiment
inocul
postinfect
day
pid
swab
process
describ
foley
et
al
briefli
swab
vortex
ml
doubledistil
water
suspens
centrifug
g
minut
pid
cat
kill
gross
histopatholog
examin
carri
follow
tissu
sampl
collect
rtpcr
brain
cortex
medulla
oblongata
dura
mater
liver
kidney
spleen
lymph
node
lung
small
larg
intestin
pancrea
third
eyelid
heart
muscl
organ
sampl
per
cent
wv
suspens
prepar
doubledistil
water
centrifug
g
minut
supernat
use
immedi
rna
extract
store
supernat
faec
tissu
homogen
use
rna
prepar
procedur
boom
et
al
cheung
et
al
follow
suspens
ad
sizefraction
silica
lysi
buffer
g
guanidin
thiocyan
dissolv
ml
trishcl
ph
ml
edta
ph
g
triton
sampl
vortex
left
minut
room
temperatur
supernat
remov
quick
spin
g
minut
silicarna
pellet
wash
twice
wash
buffer
g
guanidin
thiocyan
dissolv
ml
trishcl
ph
twice
ml
vv
ethanol
final
wash
ml
aceton
pellet
dri
minut
rna
elut
resuspend
pellet
diethyl
pyrocarbonatetr
depc
water
minut
pellet
silica
particl
g
minut
supernat
fluid
contain
rna
use
revers
transcript
cdna
synthesi
perform
reaction
mixtur
preliminari
mixtur
contain
rna
depctreat
water
random
hexam
u
pharmacia
biotech
uppsala
sweden
incub
minut
rna
denatur
tube
place
ice
rtmix
contain
deoxynucleotid
triphosph
mm
pharmacia
reaction
buffer
trishcl
ph
kcl
mm
mgcl
rnaguard
u
pharmacia
moloney
murin
leukaemia
viru
revers
transcriptas
u
gibco
brl
bethesda
md
usa
ad
reaction
mixtur
incub
minut
follow
incub
minut
inactiv
enzym
primer
select
highli
conserv
nucleocapsid
region
fip
viru
strain
genom
vennema
et
al
use
oligo
program
nation
bioscienc
inc
plymouth
mn
usa
sequenc
primer
shown
tabl
note
npcr
appli
year
routin
diagnost
laboratori
diagnosi
fip
sever
hundr
sampl
clinic
case
found
posit
unpublish
data
two
pcr
assay
carri
volum
reaction
mixtur
contain
geneamp
pcr
buffer
ii
perkinelm
cetu
norwalk
ct
usa
primer
first
nucleocapsid
pcr
pmol
primer
first
pcr
deoxynucleotid
triphosph
mm
pharmacia
mm
mgcl
amplitaq
dna
polymeras
u
perkinelm
cetu
cdna
two
droplet
miner
oil
sigma
chemic
st
loui
mo
usa
ad
prevent
evapor
second
nest
pcr
assay
perform
amount
first
pcr
product
pmol
primer
nucleocapsid
pmol
primer
follow
temperatur
profil
use
second
second
second
first
five
cycl
minut
second
round
amplif
second
minut
minut
appli
cycl
profil
repeat
time
follow
final
extens
step
minut
amplifi
dna
product
detect
standard
per
cent
agaros
gelelectrophoresi
avoid
fals
posit
neg
result
precaut
routin
diagnost
pcr
laboratori
use
throughout
experi
sensit
two
pcr
assay
evalu
compar
test
dilut
tissu
cultur
supernat
refer
viru
strain
black
clinic
sampl
rectal
swab
heart
muscl
homogen
origin
cat
concentr
nucleic
acid
solut
determin
spectrophotomet
genequ
rnadna
calcul
pharmacia
uppsala
sweden
serial
dilut
test
two
pcr
assay
show
sensit
calcul
pg
ml
total
rna
minim
target
visibl
pcr
product
obtain
shown
order
gener
singl
strand
pcr
product
sscp
analysi
asymmetr
pcr
perform
amount
complet
first
pcr
mixtur
use
nest
primer
ratio
pmol
cycl
profil
appli
second
round
amplif
five
microlitr
amount
singl
strand
pcr
product
ad
sscp
load
buffer
per
cent
formamid
per
cent
xylen
cyanol
per
cent
bromophenol
blue
kept
minut
put
ice
minut
final
load
onto
per
cent
polyacrylamid
gel
biorad
hercul
ca
usa
electrophoresi
perform
mini
protean
cell
biorad
v
constant
power
hour
room
temperatur
subsequ
gel
submerg
ml
ethidiumbromid
solut
minut
visualis
uv
light
experiment
infect
clinic
statu
cat
sever
affect
mild
diarrhoea
observ
among
experiment
infect
anim
pid
appetit
behaviour
bodi
temperatur
remain
normal
bodi
weight
cat
increas
per
cent
end
experi
test
swab
sampl
npcr
assay
gave
consist
result
cat
no
fcov
detect
occas
test
anim
viru
detect
variou
occas
shown
test
larg
intestin
npcr
assay
viru
detect
eight
anim
cat
no
neg
cat
no
viru
also
demonstr
follow
organ
cat
cortex
dura
mater
lung
pancrea
third
eyelid
heart
muscl
cat
third
eyelid
heart
muscl
cat
no
heart
muscl
region
detect
larg
intestin
eight
anim
npcr
assay
also
demonstr
pancrea
cat
heart
muscl
cat
no
sscp
assay
quasispeci
natur
detect
virus
reveal
illustr
fig
band
lane
repres
viral
subpopul
slight
nucleotid
sequenc
differ
estivil
gener
n
region
show
higher
variabl
region
consist
pattern
confirm
repeat
pcrsscp
analys
data
shown
chang
viral
quasispeci
larg
intestin
cat
fig
c
could
characteris
follow
day
infect
appear
one
major
one
minor
variant
viru
subpopul
pid
addit
minor
variant
latter
remain
termin
experi
pid
first
minor
variant
appear
replac
third
minor
variant
pid
also
remain
present
end
major
variant
alway
present
throughout
experi
never
replac
third
minor
variant
sequenc
n
gene
appear
pid
might
correl
variant
gene
sequenc
fig
cat
fig
major
minor
n
variant
present
day
like
variant
present
throughout
experi
day
pid
appear
disappear
addit
minor
subpopul
chang
region
show
similar
characterist
moder
extent
nsscp
pattern
organ
homogen
swab
sampl
demonstr
fig
appar
organ
consist
contain
three
predomin
variant
pattern
organ
substanti
pattern
swab
shown
recent
studi
suggest
fecv
parent
fipv
alter
genom
harmless
parent
lead
develop
fatal
diseas
infecti
periton
vennema
et
al
herrewegh
et
al
poland
et
al
vennema
et
al
consid
fecv
extrem
widespread
cat
popul
foley
et
al
detail
studi
requir
investig
biolog
two
viru
biotyp
particular
regard
genet
stabil
fecv
genom
region
fig
sscp
pattern
product
amplifi
nucleocapsid
region
specif
pcr
organ
sampl
cat
lane
repres
follow
organ
cortex
dura
mater
lung
larg
intestin
pancrea
heart
muscl
third
eyelid
respons
develop
virus
high
pathogen
investig
reli
abil
detect
characteris
differ
virus
variou
stage
infect
present
studi
investig
invas
tissu
distribut
variabl
fcov
aim
establish
compar
two
pcr
assay
respect
applic
monitor
purpos
appli
assay
amplifi
two
conserv
region
fcov
genom
found
eight
cat
shed
viru
faec
throughout
cours
experi
find
support
observ
herrewegh
et
al
report
fcov
infect
maintain
chronic
infect
carrier
shortlast
mild
diarrhoea
observ
among
experiment
infect
anim
earli
stage
infect
could
clinic
symptom
fcev
infect
may
consequ
massiv
exposur
anim
fcov
suggest
foley
et
al
two
cat
no
becam
remain
pcrneg
rel
earli
stage
experi
might
strong
effect
immun
respons
fcov
crucial
step
pathogenesi
fip
certain
viru
variant
leav
intestin
reach
differ
organ
pedersen
et
al
known
long
process
take
condit
requir
event
present
experi
show
despit
rel
short
observ
period
day
one
cat
fcov
appar
invad
differ
organ
consid
suggest
pedersen
et
al
may
import
step
develop
fip
interest
n
assay
gave
ident
result
swab
larg
intestin
sampl
test
howev
case
addit
organ
npcr
score
consider
posit
sampl
obviou
explan
would
differ
sensit
two
system
like
howev
consid
two
assay
yield
ident
result
swab
larg
intestin
sampl
also
serial
dilut
fcov
clinic
specimen
test
therefor
hypothesis
virus
detect
cat
could
presum
region
affect
delet
phenomenon
report
avirul
tissu
cultur
adapt
felin
coronavirus
conclud
loss
virul
associ
delet
region
de
groot
horzinek
accord
vennema
et
al
well
virul
factor
presenc
region
advantag
viru
replic
therefor
phenomenon
investig
vitro
vivo
studi
also
involv
region
consid
exert
regulatori
effect
vennema
et
al
quasispeci
natur
member
coronavirida
famili
well
document
mainli
murin
coronavirus
makino
et
al
baric
et
al
holland
et
al
lai
present
studi
reveal
fcov
also
compris
viru
subpopul
howev
differ
preval
viral
subpopul
bodi
compart
ie
variant
present
swab
sampl
present
organ
sampl
variant
preval
organ
sampl
larg
intestin
addit
vivo
replic
sscp
pattern
n
region
show
higher
variabl
region
find
suggest
presum
select
viru
variant
becam
abl
leav
larg
intestin
invad
blood
circul
differ
organ
appear
howev
select
pressur
n
gene
sinc
predomin
subpopul
master
sequenc
could
demonstr
npcr
posit
organ
specimen
nevertheless
presum
new
select
process
take
place
everi
infect
organ
may
result
viru
quasispeci
differ
composit
origin
replic
larg
intestin
process
conjunct
rel
impair
reaction
respect
immun
respons
particular
cat
could
eventu
lead
develop
fip
present
studi
demonstr
fcov
abl
establish
chronic
enter
infect
cat
data
indic
virus
undergo
continu
subtl
chang
chronic
replic
extent
variat
composit
viral
quasispeci
differ
organ
addit
even
neighbour
genom
region
show
distinct
variabl
n
region
vari
region
possibl
role
viru
replic
indic
highli
conserv
sscp
pattern
region
exhibit
throughout
experi
exact
inform
product
reveal
role
region
develop
fip
conclus
studi
provid
inform
concern
altern
genom
fcov
vivo
replic
shown
composit
viral
quasispeci
differ
organ
genom
region
differ
function
undergo
distinct
process
select
consid
evolut
felin
coronavirus
futur
investig
aim
determin
signific
chang
particular
viral
genom
region
beyond
immun
respons
fcov
infect
probabl
impair
function
eventu
particip
pathogenesi
fip
elabor
